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   In order to investigate the changes of serum lipoproteins in pulmonary 
diseases, the ultracentrifugal determination of serum low-density lipopro-
teins was performed on patients of pulmonary tuberculosis and on control. 
   The ultracentrifugal determination was also performed on the rabbits 
affected by experimentally induced pulmonary tuberculosis and aseptic 
pneumonia and on control. BETA-L test for the determination of serum 
beta-lipoprotein and paper electrophoretical analysis for the determination 
of beta/alpha lipoprotein ratio were also performed on patients of pulmo-
nary tuberculosis and clinically healthy subjects as control. Serum low-
density lipoproteins did not show any significant difference in the concen-
tration, but alpha-lipoprotein was observed to decrease in pulmonary 
tuberculosis of man in contrast to the control. On the other hand, in 
experimentally induced pulmonary tuberculosis and aseptic pneumonia of 
the rabbit, low-density lipoproteins were demonstrated to increase, mar-
kedly, but no demonstrable changes were observed in the 3-week group of 
aseptic pneumonia. Discussion was made on the difference of changes of 
lipoprotein between man and the rabbit with pulmonary lesions. The 
results obtained in this study suggested that the lungs had also an active 
role to play in the process of lipid transport in regard to lipid metabolism.
                  INTRODUCTION 
   Lipid differs from protein and carbohydrate in being mostly trans-
ported first to the lungs by way of lymph channels, thoracic duct and 
superior vena cava-. This fact suggests a possibilty for the lungs to 
play some specific role in lipid metabolism. 
    Since POPJAK ann BEECKMANSI, INDERBITZIN2 ) and SCHRADE and BIE-
GLER3) reported on the relationships of the lungs to lipid metabolism, 
some investigators have paid attention to the lungs in regard to lipid 
metabolism. 
   The metabolism of lipids in pulmonary diseases, especially in pul-
monary tuberculosis, has also been studied by OsAJIMA4)5)6)7)8)9)10)11)12)
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and co-workers since . 1959. Recently, GoFMAN et al. 13' 14' introduced 
the ultracentrifugal method for the study of serum lipoproteins. By 
this method it has been generally recognized that most of serum lipids 
exist in the form of lipoprotein13'15', that lipoproteins constitute phy-
siologic units participating in the transport of lipid S131151 and that 
intracellular lipid metabolism is also performed in the form of lipopro-
tein. Consequently, thuugh it is no doubt a useful method for the 
study of lipid metabolism to observe serum concentration of individual 
lipid components such as triglyceride, phospholipid or cholesterol, 
study on serum lipoproteins themselves may also prove helpful. 
   There are various kinds of methods for the determination of 
lipoproteins; chemical fractionation, electrophoresis, ultracentrifugation 
and immunological procedure. The ultracentrifugal method is superior 
to the others, because serum lipoproteins can be estimated as they are 
in vivo without being subjected to any chemical interactions and can 
be divided into some fractions for quantitative analysis. 
   It is the purpose of this study to investigate the changes of serum 
lipoproteins in pulmonary diseases. By means of ultracentrifugal me-
thod, serum low-density lipoproteins, the changes of which have 
hitherto been demonstrated in various disorders"', were estimated in 
pulmonary tuberculosis of man and in experimentally induced pulmona-
ry tuberculosis and aseptic pneumonia of the rabbit. 
   In human pulmonary tuberculosis serum beta-lipoprotein, which is 
considered to correspond approximately to low-density lipoproteins" , 
was also estimated by BETA-L test, and beta/alpha lipoprotein ratios 
were determined by paper electrophoresis. 
              MATERIALS AND METHODS 
   The ultracentrifugal determination of serum low-density lipoproteins 
was performed on 10 clinically healthy subjects as control and 9 patients 
with pulmonary tuberculosis, whose lesion types mainly consisted of 
C type according to Gakken classification. The age of the healthy 
subjects and patients was limited to 30 to 39 years in order to eliminate 
the influence of age factor. 
   As experimental animals for the ultracentrifugal determination, 
adult rabbits weighing 2.5kg to 3.0kg were used. The animals were 
divided into 6 groups. Twelve rabbits in group I were used as control, 
which had not received any treatments. Ten rabbits in group II were 
subjected to the determination 2 weeks after direct injection of tubercle 
bacilli into the right lung to cause pulmonary tuberculosis and 11 
rabbits in group III were subjected to the determination 5 weeks after 
the same treatment. Five rabbits in group IV were subjected to the 
determination one week after intratracheal administration of 0.1 per
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 cent silver nitrate solution to cause aseptic pneumonia; 7 rabbits in 
 group V, 2 weeks after; 6 rabbits in group VI, 3 weeks after the 
 same treatment. 
    BETA-L test for the determination of serum beta-lipoprotein and 
 paper electrophoretical analysis for the determination of beta/alpha 
 lipoprotein ratio were performed on 54 patients of pulmonary tuber-
 culosis and on 17 clinically healthy subjects as control. These patients 
 and controls were intentionally selected so that the age ranged from 30 
 to 39 years. 
    Pulmonary tuberculosis of the rabbits was caused by the experi-
 mental method devised by YAMAMURA et al. 18)19) 
    In order to cause aseptic pneumonia in the rabbits, 3cc to 5cc of 0.1 
 per cent of silver nitrate solution was injected into the trachea under 
 nembutal anesthesia according to the method reported by NISHIMURA20). 
    All experimental animals were kept on the same diet and in the 
 same conditions except for the above-mentioned treatments throughout 
this study. All blood specimens for this study were obtained from 
cubital vein in man and from abdominal aorta in the rabbit after 
fasting for 10 to 15 hours. 
    The concentrations of serum low-density lipoproteins were deter-
 mined by the ultracentrifugal method reported by OSHIMA21) et al. and 
 YASUGI and HONMA22). 
    Isolation of lipoproteins was accomplished after 15 hours centrifuga-
tion in a Hitachi Model 40P ultracentrifuge at 40.000 r. p. m. in an 
RP40 roter. 
    Analytical ultracentrifugation for quantitative determination of serum 
low-density lipoproteins was performed in a Hitachi Model U C A-1 
analytical ultracenrifuge at 52,640 r.p.m. in an RA60 roter. 
    BETA-L test was made using antihuman beta-lipoprotein precipitin 
serum produced by Hyland Laboratories24). 
    Paper electrophoresis was made according to the method reported 
by SWAHN24) . 
                     RESULTS 
    Table 1 shows the concentrations of serum low-density lipoprotein 
for each fraction in clinically healthy subjects as control. Mean values 
and standard deviations are presented in the bottom line. 
    Table 2 shows the concentrations of serum low-density lipoprotein 
in each fraction of patients with pulmonary tuberculosis. 
    A comparison of mean values of low-density lipoprotein levels 
between the patients and the control is shown in Fig. 1. Mean of 
each fraction in patients tended to decrease in contrast to that in 
normal, but the difference was not statistically significant. Consequ-
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ently, it might be said that the concentrations of low-density lipoprote-
ins in human pulmonary tuberculosis presented no significant changes. 
   The concentrations of serum low-density lipoproteins in normal 
rabbits used as control (group I) are shown in Table 3. 
   The concentrations of serum low-density lipoproteins in experimen-
tally induced pulmonary tuberculosis of the rabbits are shown in Table 
4 (group II) and in Table 5 (group III). 
                        Table 1 
         Serum Low-Density Lipoproten Levels in Normal 
         Subjects Aged Thirty to Thirty-nine Years




Sf 100-400 Sf 20-400 Sf 0-400No, Age Sex SfSf
I Sf
Sf
1 35 M 126 11 137 21 0 21 158
2 31 M 93 10 103 25 5 30 133
3 32 M 256 50 306 100 4 104 410
4 30 M 209 28 237 96 3 99 336
5 30 F 182 6 188 13 0 13 201
6 31 M 102 0 102 17 0 17 119
7 39 F 114 7 121 68 21 89 210
8 31 F 189 4 193 21 0 21 214
2189 32 F 178 18 196 22 0
10 31 M 229 11 240 27 27 54 294
S.D. 168±51 15±13 182±64 41±32 6 ± 9 47± 5 229±87Mean
                 Table 2 
Serum Low-Density Lipoprotein Levels in Patients of 
Pulmonary Tuberculosis Aged Thirty to Thirty-nine 
Years (Values Expressed in mg/100ml)




of S f 100-4001 Sf 20-400 Sf -400No, Age Sex I
0 31 1511 35 F C3KY1 120 0 120 3
2 35 F F 167 4 171 17 0 17 188
3 36 F F 146 10 156 53 4 57 213
4 36 M CP1v 170 7 177 58 0 58 235
5 34 F C3 250 17 267 65 4 69 336
100 10 110 0 0 0 1106 30 M C
7 35 M C3Kz 175 17 192 39 5 44 236
8 39 F C2K y1 133 18 151 25 0 25 176
9 31 M C2Kb1 195 17 212 47 19 66 278
Mean Valae & S. D. 162±42 11± 6 173±45 37±20 4 ± 6 41±23 214±64
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   A comparison of means of serum low-density lipoprotein levels 
between the rabbits affected by pulmonary tuberculosis and the control 
group is shown in Fig. 2. 
   Mean concentrations of all fractions were elevated in tuberculosis 
groups, especially in the 2-week group (group II) . In the 2-week 
group, the concentrations were significantly elevated in SfO-12 (P: 
0.01), SfO-20 (P:0.01), Sf20-100 (P:0.05), Sf20-400 (P:0.05) and 
SfO-400 (P:0.01) fractions. In other fractions tendency of elevation 
was observed but no significant difference was detected. 
   In the 5-week group (group III), the concentrations were signifi-
cantly elevated in SfO-12 (P:0.01), SfO-20 (P:0.01) and SfO-400 
(P:0.01) fractions. In other fractions, tendency of elevation was obser-
ved but no significant difference was demonstrated. Therefore, it
Fig. 1 Comparison of Mean Values of Low-Density Lipoprotein 
       Levels between Patients of Pulmonary Tuberculosis 
       and Matched Control
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might be said that serum low-density lipoprotein in experimentally 
induced pulmonary tuberculosis of the rabbits presented remarkable 
increase which was mainly due to the increase of SfO-20 fraction, 
especially of Sf0 -12 fraction. 
   The concentrations of low-density lipoproteins in aseptic pneumonia 
of the rabbits which was caused by the intratracheal administration 
                        Table 3 
      Serum Low-Density Lipoprotein Levels in Normal Rabbits 





- Sf - 0 Sf0No, Sf 0-12 I Sf 12-20 20 S20000400 Sf 20-400 Sf 0-400
1 33 7 40 0 0 0 40
2 46 0 46 9 0 9 55
3 66 0 66 0 0 0 66
4 143 4 147 13 0 13 160
5 101 33 134 13 0 13 147
6 78 24 102 28 0 28 130
7 107 59 166 46 12 58
8 145 47 192 34 21 55 247
9 41 0 41 0 0 0 41
10 48 7 55 4 17 21 76
11 45 0 45 9 14 23 68
12 53 21 74 17 0 17 I 91
112±67-52_13_8S
.D. 7638 1720
                  Table 4 
Serum Low-Density Lipoprotein Levels in Rabbits Two 
Weeks after Injection of Tubercle Bazilli into the Lung 
         (Values Expressed in mg/100ml)
100-40020-10012-200-20
286±132193±93231±110±±
Sf 20-400 Sf 0-400No. Sf 0-12 SfSfSfSf
1 408 46 454 40 0 40 494
2 185 38 223 63 0 63 286
3 306 93 399 121 24 145 544
4 169 104 273 82 0 82 355
5 154 7 161 9 0 9 170
6 137 14 151 13 0 13 164
7 240 7 247 9 3 9 256
8 103 30 133 110 21 131 264
9 110 16 126 22 0 22 148
42 18210 119
_ 9 56 ± 4738 _ 325_ 4M ' D
21 140 27 15
+00 6
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of 0. 1 per cent silver nitrate solution are shown in Table 6 (group 
IV), Table 7 (group V) and Table 8 (group VI). 
   A comparison of means of low-density lipoprotein levels between 
the rabbits affected by aseptic pneumonia and the control is shown 
in Fig. 3. 
   The concentration of all fractions were markedly elevated in aseptic 
pneumonia groups except in the 3-week group (group VI). 
   The concentration of SfO-20 fraction was more markedly elevated 
in the one-week group (group IV) than in the 2-week group (group 
V). On the other hand, the elevation of the concentration of Sf20-
                  Table 5 
Serum Low-Density Lipoprotein Levels in Rabbits Five 
Weeks after Injection of Tubercle Bazilli into the Lung 
        (Values Expressed in mg/100 ml)
-20 5f 0-20 Sf 20-100 Sf 100-400
161±223±70184±58S. I
No. Sf 0-12 Sf 12Sf 20-400 5f 0-400
1 140 0 140 0 0 0 140
2 238 63 301 40 0 40 341
3 105 14 119 24 0 24 143
4 91 35 126 43 8 51 177
5 157 25 182 89 18 107 289
6 118 37 155 14 26 40 195
7 123 0 123 11 18 29 152
8 230 25 255 35 0 35 290
9 149 7 156 .13 0 13 169
10 215 18 233 14 0 14 247
11 209 29 283 65 4 69 307
50 23 ± 1432 ± 25 7 ± 9 38 ± 28' D
                  Table 6 
serum Low-Density Lipoprotein Levels in Rabbits One 
Week after Intratracheal Administration of Silver Nitrate 
iolution to Cause Aseptic Pneumonia 
        (Values Expressed in mg/100 ml)
-20 Sf 0-20 Sf 20-100 Sf100 -
± ±M. &
No. Sf 0-12 Sf 124001 Sf 20-400 Sf 0-400
1 105 31 136 46 0 46 182
2 104 18 122 18 0 18 140
3 120 9 129 18 0 18 147
4 293 22 315 9 19 28 343
113 41 154 62 41 103 2575
_ _ _ 16 43 ±32 214±75S
. D. 14773 24 ±
12 171 +33 3120 12
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400 fraction was more remarkable in the 2-week group (group V) than 
in the one-week group (group IV). 
   In the one-week group, the concentrations of SfO-12 (P:0.05), 
SfO-20 (P:0.05) and SfO-400 fraction (P-:0.05) were significantly 
elevated. In other fraction (P:0.05) were significantly elevated. In 
other fractions, the concentrations tended to be elevated but 'did not 
reveal any significant difference. 
   In the 2-week group, the concentrations were significantly eleva-
Fig. 2 Comparison of Mean Values of Low-Density Lipoprotein 
       Levels between Rabbits Affected by Pulmonary Tuber-
       culosis and Matched Control
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ted in Sf12-20 (P:0.01), Sf20-100 (P:0.05), Sf100-400 (P:0.05), Sf20 
-400 (P:0 .05) and SfO-400 (P:0.05) fractions. In SfO-12 and SfO-
20 fractions, the concentrations tended to be elevated but -revealed no 
significant difference. 
   In the 3-week group, the concentration of each fraction tended to 
be slightly elevated in contrast to those of the control, but no statisti-
cally significant difference was demonstrated. 
   As mentioned above, BETA-L test for the determination of beta-
lipoprotein was performed on 17 clinically healthy subjects as control 
and on 54 patients of pulmonary tuberculosis. The type of their 
tuberculous lesions was type C according to Gakken classification.
                  Table 7 
Serum Low-Density Lipoprotein Levels in Rabbits Two 
Weeks after Intratracheal Administration of Silver 
Nitrate Solution to Cause Aseptic Pneumonia 
         (Values Expressed in mg/100 ml)
-20 Sf 0-20 Sf 20-100 Sf 100-4001
'116
132±29205±82
No, Sf 0-12 Sf 12Sf 20-400 Sf 0-400
1 65 40 105 4 0 4 109
2 60 55 115 98 37 135 250
3 98 18 116 28 0 28 144
424 140 52 35 87 227
5 91 12 103 9 8 17 120
6 126 32 158 52 12 64 222
7 137 49 186 115 60 175 361
51 ± 39 22 ± 21 73 ± 59S . D . 99 ± 27 33 ± 15
                  Table 8 
Serum Low-Density Lipoprotein Levels in Rabbits Three 
Weeks after Intratracheal Administration of Silver Nitrate 
Solution to Cause Aseptic Pneumonia 
         (Values Expressed in mg/100 ml)
1
115±42
Sf 20-100 Sf 100-400 Sf 20-400 Sf 0-400No, Sf 0-12 Sf 12-20 Sf 0-20
1 78 7 85 22 0 22 107
2 139 12 151 4 0 4 155
3 113 23 136 5 27 32 168
4 92 8 100 I 5 18 23 123
5 48 10 58 26 8 34 92
6 42 0 42 0 0 0 42
M.& S . D 85 ± 34 10 ± 7 95 ± 39 10 ± 10 9 ± 10 19 ± 13
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The 54 patients were subdivided into 3 groups, C1, C2 and C3, accord-
ing to the extent of their tuberculous lesions. 
   The, beta/alpha lipoprotein ratios were also determined by paper 
electrophoresis and the concentration of alpha-lipoprotein was estimated 
using the data obtained from BETA/L test and paper electrophoresis. 
   The concentration of alpha-lipoprotein estimated in this way might 
be available to guess the possible changes of the alpha-lipoprotein level, 
although there seemed to be some question about it, because 231 the 
reproducibility of results obtained by paper electrophoresis for beta/ 
alpha lipoprotein ratio seemed not to be so satisfactory. 
   A comparison of means of alpha and beta-lipoprotein levels and 
beta/alpha lipoprotein ratios between the patients and clinically healthy 
subjects is shown in Fig. 4. 
   The mean concentrations of beta-lipoprotein in the patients of all 
the three groups, C1, C2 and C3 types, were within normal range. 
   The beta/alpha lipoprotein ratios were markedly elevated, so that 
the concentrations of alpha-lipoprotein appeared to decrease remarkably 
in the patients groups.
Fig. 3 Comparison of Mean Values of Low-Density Lipoprotein 
       Levels between Rabbits Affected by Aseptic Pneumonia 
       and Matched Control
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            Fig. 4 Comparison of Mean Values of a and R Lipoprotein 
                   Levels and Rl a Lipoprotein Ratio between Patients of 
                   Pulmonary Tuberculosis (C-Type) and Normal Subjects
                   DISCUSSION 
   Lipemia in human pneumonia or in lung cancer has been often 
observed by some investigators25)26,27). PRINz et a123> . and OSAJIMA et 
al4' . reported that incidence of fatty liver was considerably high in 
pulmonary tuberculosis. Though these reports suggest that disturbance 
of lipid metabolism may happen in pulmonary diseases, there have 
been but few data available for the study on serum lipoproteins in 
pulmonary diseases. 
   On application of zone electropheresis, MA'rsuo and H ATTORI29) have 
reported the demonstrable elevation of beta/alpha lipoprotein ratio in 
lung cancer as well as in pulmonary tuberculosis and pulmonary fibro-
sis. IMADA et al27). have also reported the elevation of beta/alpha 
lipoprotein ratio in pulmonary tuberculosis,
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   Studies on serum lipoprotein with special reference to serum proteine 
bound cholesterol in pulmonary tuberculosis were made by HURUTOYO5'. 
   As mentioned above, serum lipoproteins in pulmonary diseases 
have hitherto been studied by electrophoresis or chemical fractionation 
methods, but the studies on lipoprotein in the above-mentioned diseases 
by ultracentrifugal method have not as yet been reported 
   In human pulmonary tuberculosis, as already described, the eleva-
tion of beta/alpha lipoportein ratio had been demonstrated27)29)5). On 
the other hand, in this study, the concentrations of low-density lipo-
proteins determined ultracentrifugally and the concentration of beta-
lipoprotein which is considered to approximately correspond to low-
density lipoproteins17' revealed no significant difference in contrast, to 
the control. Therefore, it was interpreted that the decrease of alpha-
lipoprotein might be responsible for the elevation of the beta/alpha 
lipoprotein ratio. 
   There seemed to be good agreement between these results and 
those obtained by HURUTOYO5), who made studies on serum protein 
bound cholesterol in pulmonary tuberculosis and suggested that the 
elevation of beta/alpha lipoprotein ratio was due to the decrease of 
alpha-cholesterol, because, as a matter of course, the decrease of 
alpha-cholesterol was considered to produce the decrease of alpha-
lipoprotein. On the other hand, in experimentally induced pulmonary 
tuberculosis of the rabbits, levels of low-density lipoproteins tended to 
be markedly elevated both in the 2 - and the 5 - week groups. In the 
2-week group, SfO-20 and Sf20-400 lipoproteins were recognized to 
be significantly elevated, the increase of the former being more 
remarkable than that of the latter. 
   In the 5-week group, only SfO - 20 lipoprotein was demonstrated 
to be significantly elevated. Consequently, it could be stressed that 
an outstanding increase of SfO-20 lipoprotein, which is designated as 
the cholesterol rich or as the principal cholestero-bearingl7'so)sl)s2>ss) 
lipoprotein, was observed in pulmonary tuberculosis of the rabbits. 
The fact was also in agreement with the results obtained by HURUTOYO 
5' that beta-cholesterol level was significantly elevated and alpha-
cholesterol level did not show any significant difference, and that 
these changes were responsible for the elevation of beta/alpha choles-
terol ratio in experimentally induced pulmonary tuberculosis of the 
rabbit. 
   It was, therefore, presumed that the concentration of alpha-lipo-
protein or high-density lipoprotein might have presented no demonstra-
ble change in experimentally induced pulmonary tuberculosis of the 
rabbit, although the determination of high-density lipoprotein by ultra-
centrifugal method was not performed in this study. 
   HURUTOYO5) had reported the increase of beta-cholesterol. This 
study also demonstrated a marked increase of the principal cholesterol-
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bearing lipoproteins or SfO-20 lipoproteins, and the major glyceride-
bearing lipoproteins17)30)31)32)33) or Sf20-400 lipoproteins also tended to 
increase in pulmonary tuberculosis of the rabbit. This suggested that 
not only cholesterol but also triglyceride might increase . 
    In aseptic pneumonia of the rabbit, which was caused by the intra-
tracheal administration of silver nitrate solution, the concentrations of 
low-density lipoproteins did not show any significant difference in 
comparison with those of the control in the 3-week group (group VI). 
In the one-week group (group IV), the concentrations were significant-
ly increased in SfO-20 (P:0.05) and SfO-400 (P:0.05) fractions but, 
in the 2-week group (group V), significant increases of the concent-
rated in Sf12-20, (P:0.01) Sf20-400 (P:0.05) and SfO-400 (P:0.05) 
fractions. Comparison of experimentally induced pulmonary tuberculosis 
with aseptic pneumonia of the rabbit revealed that changes of the 
concentrations of lipoproteins were still markedly demonstrated in the 
5-week group of the tuberculosis groups, but the changes demonstra-
ted proved no longer significant in the 3-week group of the aseptic 
pneumonia groups. Such difference was considered to be due to the 
difference of histo-pathological findings of pulmonary lesions between 
tuberculosis and aseptic pneumonia. It was histologically recognized 
in this study, as well as in the study made by IKEDA34>, that reparative 
process of acute inflammation or of damaged connective tissue had 
taken place considerably earlier in aseptic pneumonia lesions than in 
tuberculosis lesions. Consequently, it was considered that the more 
remarkable and the more striking the inflamatory changes of the lung 
were, the more distinct the increase of low-density lipoproteins or 
beta-lipoprotein would be. 
   As mentioned above, in human pulmonary tuberculosis, changes 
of lipoproteins were indicative of the decrease of alphr-lipoprotein and 
not of such increase of beta-lipoprotein or low-density lipoproteins 
as demonstrated in pulmonary tuberculosis or aseptic pneumonia of the 
rabbit. 
   It seemed to be hardly possible to explain this difference between 
man and the rabbit, but it was supposed that difference of animal 
species or abnormalities of lipid metabolism in the liver might have 
something to do with it: because physiologic variations of lipoprotein 
depending on the kind of animal have been recognized 35); and OSAJIMA 
et al4' . and PRINZ et all". reported that patients with pulmonary 
tuberculosis were frequently accompanied with fatty liver also. 
   It was also surmised that histo-pathological features in the human 
pulmonary tuberculosis, which were considered to be very chronic and 
mild in the inflammatory process as compared with those in experi-
mentally induced pulmonary tuberculosis and aseptic pneumonia of the 
rabbit, were partly responsible for the difference between man and 
rabbit,
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                   CONCLUSION 
   Conclusions drawn from this study were as , follows: 
1) In pulmonary tuberculosis of man, serum low-density lipoproteins 
   or beta-lipoprotein did not show any significant difference in the 
   concentration, and alpha-lipoprotein was considered to decrease as 
   compared with the control. 
2) In experimentally induced pulmonary tuberculosis, the concentra-
   tions of serum low-density lipoproteins increased not only in SfO -
   20 fraction but also in Sf 20 - 400 fraction. 
3) It was presumed that the more distinct and the more striking th.e 
   acute inflammatory changes of the lung were, the more remarkable 
   the changes of serum lipoproteins would be. 
4) Baced on the results obtained in this study, it was suggested that 
   the lungs played some specific role also in the process of lipid 
   transport in regard to lipid metabolism. 
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